Seres Therapeutics, Inc. ($MCRB)
Filing Information
| Accession Number | 0001193125-26-057154 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 15, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
566
Total Value
$660.66
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer, EVP, Co-Chief Executive Officer, and Co-President | Common Stock | โ | Feb 15, 2026 | Exercise/Conversion | 244 | โ | โ | 7,867 | Direct | โ | View Details | |
Chief Legal Officer, EVP, Co-Chief Executive Officer, and Co-President | Common Stock | โ | Feb 15, 2026 | Sale | 78 | $8.47 | $660.66 | 7,789 | Direct | โ | View Details | |
Chief Legal Officer, EVP, Co-Chief Executive Officer, and Co-President | Restricted Stock Units | Derivative | Feb 15, 2026 | Exercise/Conversion | 133 | $0.00 | $0.00 | 531 | Direct | โ | View Details | |
Chief Legal Officer, EVP, Co-Chief Executive Officer, and Co-President | Restricted Stock Units | Derivative | Feb 15, 2026 | Exercise/Conversion | 111 | $0.00 | $0.00 | 890 | Direct | โ | View Details |